JEFMS Journal

ABSTRACT:

The main aim of this study to determine the explanatory variables of the Chinese exports of COVID-19 medical supplies to its 89 major trading partners in the first half of the year 2020. In addition, it explores the puzzle of COVID-19 pandemic outbreak from an economic perspective. We used the Ordinary-least-square (OLS) regression under a cross-sectional data framework to construct the quantitative analysis.

The main findings are: First, the number of old population and the number of COVID-19 confirmed cases in the trading partner have been drivers of Chinese exports of COVID-19 medical supplies. Second, tariff barriers levied on the trading partner significantly impedes the Chinese exports of COVID-19 medical supplies to its trade partners, especially from middle-income countries.

In future work, the analysis of this type of trade through the supply-side factors could be investigated. Also, some other variables such as non-tariff measures could be utilized. The study encourages literature for empirically analyzing the trade of medical supplies, in general, under econometric modeling. The results are illustrated based on consistent quantitative evidence.

KEYWORDS:

COVID-19, Medical supplies, Trade, China, Cross-sectional data.

REFERENCES:

1) Baltagi, B. H. (2005). Econometric Analysis of Panel Data (Third ed.). West Sussex: John Wiley & Sons Ltd.

2) Di Tommaso, M. (2020). The Globalization of China’s Health Industry: Industrial Policies, International Networks and Company Choices. Springer Nature.

3) Eriksen, S. S. (2020). China, India and the political economy of medical supplies. NUPI Covid-19 Brief.

4) Evenett, S. J. (2020). Sicken thy neighbour: The initial trade policy response to COVID-19. The World Economy, 43, pp. 828 - 839. doi:https://doi.org/10.1111/twec.12954

5) Gujarati, D. N. (2003). Basic Econometrics (Fourth ed.). McGraw Hill.

6) Ikizler, T. (2020, July 1). COVID-19 in dialysis patients: adding a few more pieces to the puzzle. Kidney International, 98(1), pp. 17-19. doi:https://doi.org/10.1016/j.kint.2020.04. 032

7) Konieczny, L., & Roterman, I. (2020, May 31). The COVID-19 Puzzle. Bioinformation, 16(5), pp. 418-421. doi:10.6026/97320630016418

8) Mikic, M. P., T, A., & James, G. G. (2020, May). Healthcare products trade and external shocks: The US-China trade war and COVID-19 pandemic. ARTNeT Working Paper Series No. 190.

9) OECD. (2020). TRADE INTERDEPENDENCIES IN COVID-19 GOODS. OECD.

10) Rochon, P., Wei, W., Vasily , G., & Nathan , M. (2020, June 14). The Missing Pieces of the COVID‐19 Puzzle. journal of the American Geriatrics Society, 68(8), pp. 1671-1673. doi:https://doi.org/10.1111/jgs.16646 Torrey, Z. (2018). China Prepares for Big Pharma.

11) The Diplomat, https://thediplomat.com/2018/03/china- prepares-for-big-pharma/.

12) Vickers, B., & Salamat, A. (2020). Prioritising the Poor: LDCs and Trade in COVID-19- Related Medical Supplies. London: Trade, Oceans and Natural Resources Directorate of the Commonwealth Secretariat.

13) Wan, F., Williamson, P. J., & Yin, E. (2015). Antecedents and implications of disruptive innovation: Evidence from China. Technovation, 39, pp. 94-104.

14) WHO. (2020). Coronavirus disease (COVID-19). World Health Organization.

15) WTO. (2020). TRADE IN MEDICAL GOODS IN THE CONTEXT OF TACKLING COVID-19. WTO.